CareView Communications (CRVW) Capital Expenditures (2010 - 2026)
CareView Communications' (CRVW) quarterly Capital Expenditures came in at $21466.0 in Q2 2026, up 549.5% year-over-year from $3305.0 in Q2 2025, and up 131.26% quarter-over-quarter from $9282.0 in Q1 2026.
Analysis
CareView Communications (CRVW) Capital Expenditures (2010 - 2026) Analysis & Trends
CareView Communications has disclosed Capital Expenditures across 17 years of filings, most recently posting $21466.0 for Q2 2026.
- In Q2 2026, Capital Expenditures rose 549.5% year-over-year to $21466.0; the TTM figure through Jun 2026 stood at $35013.0 (up 69.92% YoY), while the FY2025 annual figure was $8652.0, down 81.23% from the prior year.
- Capital Expenditures came in at $21466.0 for Q2 2026 at CareView Communications, up from $9282.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $21466.0 in Q2 2026 to a low of -$1.7 million in Q4 2022.
- Average Capital Expenditures over 5 years is -$97742.7, with a median of $5608.5 recorded in 2023.
- Year-over-year, Capital Expenditures slumped 10261.84% in 2022 and jumped 757.86% in 2026.
- Over 5 years, Capital Expenditures stood at -$1.7 million in 2022, then surged by 100.62% to $10347.0 in 2023, then retreated by 8.17% to $9502.0 in 2024, then sank by 60.15% to $3787.0 in 2025, then surged by 466.83% to $21466.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $21466.0 in Q2 2026, $9282.0 in Q1 2026, and $3787.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 51.13 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - | 21,466.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21,466.00 |
| Mar 31, 2026 | 9,282.00 |
| Dec 31, 2025 | 3,787.00 |
| Sep 30, 2025 | 478.00 |
| Jun 30, 2025 | 3,305.00 |
| Mar 31, 2025 | 1,082.00 |
| Dec 31, 2024 | 9,502.00 |
| Sep 30, 2024 | 6,716.00 |
| Jun 30, 2024 | 20,659.00 |
| Mar 31, 2024 | 9,219.00 |
| Dec 31, 2023 | 10,347.00 |
| Sep 30, 2023 | 4,501.00 |
| Jun 30, 2023 | 17,363.00 |
| Mar 31, 2023 | -15,420.00 |
| Dec 31, 2022 | -1.66 Mn |
| Mar 31, 2022 | -4,099.00 |
| Dec 31, 2021 | 16,356.00 |
| Sep 30, 2021 | 43,770.00 |
| Jun 30, 2021 | 43,213.00 |
| Mar 31, 2021 | -4,098.00 |